Form 8-K - Current report:
SEC Accession No. 0001641172-25-012917
Filing Date
2025-05-30
Accepted
2025-05-29 19:46:15
Documents
17
Period of Report
2025-05-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 58312
2 EX-4.1 ex4-1.htm EX-4.1 54696
3 EX-4.2 ex4-2.htm EX-4.2 43799
4 EX-10.1 ex10-1.htm EX-10.1 297155
5 EX-10.2 ex10-2.htm EX-10.2 47288
6 EX-10.3 ex10-3.htm EX-10.3 117534
  Complete submission text file 0001641172-25-012917.txt   888019

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE mgrx-20250515.xsd EX-101.SCH 3032
8 XBRL LABEL FILE mgrx-20250515_lab.xml EX-101.LAB 34239
9 XBRL PRESENTATION FILE mgrx-20250515_pre.xml EX-101.PRE 22370
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3848
Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Filer) CIK: 0001938046 (see all company filings)

EIN.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41615 | Film No.: 251005723
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)